Report Detail

Request for Sample of this report

Pharma & Healthcare Global Nuclear Medicine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2982274
    • |
  • 19 February, 2019
    • |
  • Global
    • |
  • 123 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:
The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
The worldwide market for Nuclear Medicine is expected to grow at a CAGR of roughly 7.6% over the next five years, will reach 6610 million US$ in 2024, from 4590 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nuclear Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other

Market Segment by Applications, can be divided into
Diagnostic
Therapeutic

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine, with price, sales, revenue and global market share of Nuclear Medicine in 2017 and 2018.
Chapter 3, the Nuclear Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Nuclear Medicine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Tc-99
      • 1.2.2 I-123/131
      • 1.2.3 In-111
      • 1.2.4 Xe-133
      • 1.2.5 Th-201
      • 1.2.6 Ga-67
      • 1.2.7 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Diagnostic
      • 1.3.2 Therapeutic
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GE Healthcare
      • 2.1.1 Business Overview
      • 2.1.2 Nuclear Medicine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GE Healthcare Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Bracco Imaging
      • 2.2.1 Business Overview
      • 2.2.2 Nuclear Medicine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Bracco Imaging Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Mallinckrodt
      • 2.3.1 Business Overview
      • 2.3.2 Nuclear Medicine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Mallinckrodt Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Lantheus Medical Imaging
      • 2.4.1 Business Overview
      • 2.4.2 Nuclear Medicine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Lantheus Medical Imaging Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Bayer
      • 2.5.1 Business Overview
      • 2.5.2 Nuclear Medicine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Bayer Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Triad Isotopes
      • 2.6.1 Business Overview
      • 2.6.2 Nuclear Medicine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Triad Isotopes Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Nordion
      • 2.7.1 Business Overview
      • 2.7.2 Nuclear Medicine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Nordion Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Jubilant Pharma
      • 2.8.1 Business Overview
      • 2.8.2 Nuclear Medicine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Jubilant Pharma Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Eli Lilly
      • 2.9.1 Business Overview
      • 2.9.2 Nuclear Medicine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Eli Lilly Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 SIEMENS
      • 2.10.1 Business Overview
      • 2.10.2 Nuclear Medicine Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 SIEMENS Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 China Isotope & Radiation
      • 2.11.1 Business Overview
      • 2.11.2 Nuclear Medicine Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 China Isotope & Radiation Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Dongcheng
      • 2.12.1 Business Overview
      • 2.12.2 Nuclear Medicine Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Dongcheng Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Nuclear Medicine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Nuclear Medicine Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Nuclear Medicine Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Nuclear Medicine Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Nuclear Medicine Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Nuclear Medicine Market Analysis by Regions

    • 4.1 Global Nuclear Medicine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Nuclear Medicine Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Nuclear Medicine Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.3 Europe Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.5 South America Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Nuclear Medicine Sales and Growth Rate (2014-2019)

    5 North America Nuclear Medicine by Country

    • 5.1 North America Nuclear Medicine Sales, Revenue and Market Share by Country
      • 5.1.1 North America Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 5.3 Canada Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Nuclear Medicine Sales and Growth Rate (2014-2019)

    6 Europe Nuclear Medicine by Country

    • 6.1 Europe Nuclear Medicine Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.3 UK Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.4 France Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.5 Russia Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.6 Italy Nuclear Medicine Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Nuclear Medicine by Country

    • 7.1 Asia-Pacific Nuclear Medicine Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 7.2 China Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.3 Japan Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.4 Korea Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.5 India Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Nuclear Medicine Sales and Growth Rate (2014-2019)

    8 South America Nuclear Medicine by Country

    • 8.1 South America Nuclear Medicine Sales, Revenue and Market Share by Country
      • 8.1.1 South America Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Nuclear Medicine Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Nuclear Medicine by Countries

    • 9.1 Middle East and Africa Nuclear Medicine Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Nuclear Medicine Sales and Growth Rate (2014-2019)

    10 Global Nuclear Medicine Market Segment by Type

    • 10.1 Global Nuclear Medicine Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Nuclear Medicine Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Nuclear Medicine Revenue and Market Share by Type (2014-2019)
    • 10.2 Tc-99 Sales Growth and Price
      • 10.2.1 Global Tc-99 Sales Growth (2014-2019)
      • 10.2.2 Global Tc-99 Price (2014-2019)
    • 10.3 I-123/131 Sales Growth and Price
      • 10.3.1 Global I-123/131 Sales Growth (2014-2019)
      • 10.3.2 Global I-123/131 Price (2014-2019)
    • 10.4 In-111 Sales Growth and Price
      • 10.4.1 Global In-111 Sales Growth (2014-2019)
      • 10.4.2 Global In-111 Price (2014-2019)
    • 10.5 Xe-133 Sales Growth and Price
      • 10.5.1 Global Xe-133 Sales Growth (2014-2019)
      • 10.5.2 Global Xe-133 Price (2014-2019)
    • 10.6 Th-201 Sales Growth and Price
      • 10.6.1 Global Th-201 Sales Growth (2014-2019)
      • 10.6.2 Global Th-201 Price (2014-2019)
    • 10.7 Ga-67 Sales Growth and Price
      • 10.7.1 Global Ga-67 Sales Growth (2014-2019)
      • 10.7.2 Global Ga-67 Price (2014-2019)
    • 10.8 Other Sales Growth and Price
      • 10.8.1 Global Other Sales Growth (2014-2019)
      • 10.8.2 Global Other Price (2014-2019)

    11 Global Nuclear Medicine Market Segment by Application

    • 11.1 Global Nuclear Medicine Sales Market Share by Application (2014-2019)
    • 11.2 Diagnostic Sales Growth (2014-2019)
    • 11.3 Therapeutic Sales Growth (2014-2019)

    12 Nuclear Medicine Market Forecast (2019-2024)

    • 12.1 Global Nuclear Medicine Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Nuclear Medicine Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.2 Europe Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.4 South America Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Nuclear Medicine Market Forecast (2019-2024)
    • 12.3 Nuclear Medicine Market Forecast by Type (2019-2024)
      • 12.3.1 Global Nuclear Medicine Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Nuclear Medicine Market Share Forecast by Type (2019-2024)
    • 12.4 Nuclear Medicine Market Forecast by Application (2019-2024)
      • 12.4.1 Global Nuclear Medicine Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Nuclear Medicine Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Nuclear Medicine . Industry analysis & Market Report on Nuclear Medicine is a syndicated market report, published as Global Nuclear Medicine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,780.52
      		4,170.78
      		5,561.04
      		3,232.92
      		4,849.38
      		6,465.84
      		541,105.20
      		811,657.80
      		1,082,210.40
      		290,510.40
      		435,765.60
      		581,020.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo